{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:56:05Z","timestamp":1791971765549,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":200,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.aicoj.2026.100120","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:28:27Z","timestamp":1784647707000},"page":"100120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diuretic therapy for critically ill patients: a systematic review and network meta-analysis"],"prefix":"10.1016","volume":"16","author":[{"given":"Akira","family":"Kuriyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Polok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Kuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Pitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Lakhanpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil Dev","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitryn","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Burry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward G.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Hylander","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley B.","family":"Gershengorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.aicoj.2026.100120_bib0005","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1513\/AnnalsATS.201504-187OC","article-title":"Volume overload: prevalence, risk factors, and functional outcome in survivors of septic shock","volume":"12","author":"Mitchell","year":"2015","journal-title":"Ann Am Thorac Soc."},{"issue":"1","key":"10.1016\/j.aicoj.2026.100120_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/SHK.0000000000000268","article-title":"Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death","volume":"43","author":"Kelm","year":"2015","journal-title":"Shock."},{"issue":"12","key":"10.1016\/j.aicoj.2026.100120_bib0015","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/CCM.0000000000004617","article-title":"Fluid overload and mortality in adult critical care patients-a systematic review and meta-analysis of observational studies","volume":"48","author":"Messmer","year":"2020","journal-title":"Crit Care Med."},{"issue":"1","key":"10.1016\/j.aicoj.2026.100120_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13613-023-01178-x","article-title":"Impact of a cumulative positive fluid balance during the first three ICU days in patients with sepsis: a propensity score-matched cohort study","volume":"13","author":"Hyun","year":"2023","journal-title":"Ann Intensive Care."},{"issue":"1","key":"10.1016\/j.aicoj.2026.100120_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12871-025-03518-9","article-title":"Fluid balance and mortality in adult ICU patients with sepsis or septic shock: a systematic review and meta-analysis of observational studies","volume":"26","author":"Fonda","year":"2025","journal-title":"BMC Anesthesiol."},{"issue":"24","key":"10.1016\/j.aicoj.2026.100120_bib0030","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMoa062200","article-title":"Comparison of two fluid-management strategies in acute lung injury","volume":"354","author":"Wiedemann","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aicoj.2026.100120_bib0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/CEOR.S45873","article-title":"Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals","volume":"5","author":"Magee","year":"2013","journal-title":"Clinicoecon Outcomes Res."},{"key":"10.1016\/j.aicoj.2026.100120_bib0040","first-page":"1","article-title":"The costs of fluid overload in the adult intensive care unit: is a small-volume infusion model a proactive solution?","volume":"7","author":"Child","year":"2015","journal-title":"Clinicoecon Outcomes Res."},{"issue":"7","key":"10.1016\/j.aicoj.2026.100120_bib0045","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s40262-025-01524-1","article-title":"Clinical pharmacology of loop diuretics in critical care","volume":"64","author":"Ferrari","year":"2025","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.aicoj.2026.100120_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fneph.2022.879766","article-title":"New insights into diuretic use to treat congestion in the ICU: beyond furosemide","volume":"2","author":"Escudero","year":"2022","journal-title":"Front Nephrol."},{"issue":"6","key":"10.1016\/j.aicoj.2026.100120_bib0055","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bja.2025.02.032","article-title":"Diuretics in critically ill patients: a narrative review of their mechanisms and applications","volume":"134","author":"Coppola","year":"2025","journal-title":"Br J Anaesth."},{"issue":"4","key":"10.1016\/j.aicoj.2026.100120_bib0060","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension."},{"issue":"10","key":"10.1016\/j.aicoj.2026.100120_bib0065","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00134-025-08058-x","article-title":"European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: Part 3-fluid removal at de-escalation phase","volume":"51","author":"Ostermann","year":"2025","journal-title":"Intensive Care Med."},{"issue":"11","key":"10.1016\/j.aicoj.2026.100120_bib0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aicoj.2026.100120_bib0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081199","article-title":"Development Of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials","volume":"388","author":"Wang","year":"2025","journal-title":"BMJ."},{"key":"10.1016\/j.aicoj.2026.100120_bib0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ."},{"key":"10.1016\/j.aicoj.2026.100120_bib0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.aicoj.2026.100120_bib0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jclinepi.2018.11.025","article-title":"GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence","volume":"108","author":"Brignardello-Petersen","year":"2019","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.aicoj.2026.100120_bib0095","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.aicoj.2026.100120_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol."},{"issue":"7","key":"10.1016\/j.aicoj.2026.100120_bib0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follmann","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.aicoj.2026.100120_bib0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol."},{"issue":"3","key":"10.1016\/j.aicoj.2026.100120_bib0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials."},{"issue":"32","key":"10.1016\/j.aicoj.2026.100120_bib0120","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-Analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ."},{"issue":"6","key":"10.1016\/j.aicoj.2026.100120_bib0125","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jaci.2023.08.029","article-title":"Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials","volume":"152","author":"Chu","year":"2023","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"10.1016\/j.aicoj.2026.100120_bib0130","first-page":"62","article-title":"Continuous Versus intermittent furosemide dosing regimen in the treatment of acute decompensated heart failure","volume":"4","author":"Ahmad","year":"2023","journal-title":"BMC J Med Sci."},{"issue":"4","key":"10.1016\/j.aicoj.2026.100120_bib0135","first-page":"306","article-title":"Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion","volume":"10","author":"Apte","year":"2008","journal-title":"Crit Care Resusc."},{"key":"10.1016\/j.aicoj.2026.100120_bib0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcrc.2016.01.017","article-title":"Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients","volume":"33","author":"Bihari","year":"2016","journal-title":"J Crit Care."},{"issue":"2","key":"10.1016\/j.aicoj.2026.100120_bib0145","first-page":"50","article-title":"Benefit of add on low dose oral tolvaptan to loop diuretics among patients with acute decompensated heart failure: a randomized controlled trial","volume":"28","author":"Chitthai","year":"2022","journal-title":"J Nephrol Soc Thailand."},{"issue":"6","key":"10.1016\/j.aicoj.2026.100120_bib0150","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-9610(83)90344-6","article-title":"Diuresis with continuous infusion of furosemide after cardiac surgery","volume":"146","author":"Copeland","year":"1983","journal-title":"Am J Surg."},{"issue":"4","key":"10.1016\/j.aicoj.2026.100120_bib0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00392-019-01521-y","article-title":"Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial","volume":"109","author":"Frea","year":"2020","journal-title":"Clin Res Cardiol."},{"key":"10.1016\/j.aicoj.2026.100120_bib0160","first-page":"253","article-title":"Comparison of furosemide bolus and furosemide continuous in critical patients with fluid overload in ICU","volume":"26","author":"Impola","year":"2023","journal-title":"Crit Care Shock."},{"issue":"3","key":"10.1016\/j.aicoj.2026.100120_bib0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ehf2.12088","article-title":"Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure","volume":"3","author":"Jujo","year":"2016","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.aicoj.2026.100120_bib0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12872-016-0341-0","article-title":"The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery","volume":"16","author":"Kato","year":"2016","journal-title":"BMC Cardiovasc Disord."},{"issue":"4","key":"10.1016\/j.aicoj.2026.100120_bib0175","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1253\/circj.CJ-17-0967","article-title":"Can tolvaptan protect renal function in the early postoperative period of cardiac surgery?\u3000- Results of a single-center randomized controlled study","volume":"82","author":"Kishimoto","year":"2018","journal-title":"Circ J."},{"key":"10.1016\/j.aicoj.2026.100120_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.155002","article-title":"Furosemide with adjunctive acetazolamide vs furosemide only in critically ill patients: A pilot two-center randomized controlled trial","volume":"86","author":"Maeda","year":"2025","journal-title":"J Crit Care."},{"issue":"6","key":"10.1016\/j.aicoj.2026.100120_bib0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/tcic.8.6.273.276","article-title":"Frusemide in pulmonary oedema: continuous versus intermittent","volume":"8","author":"Makhoul","year":"1997","journal-title":"Clin Intensive Care."},{"issue":"9B","key":"10.1016\/j.aicoj.2026.100120_bib0190","first-page":"3551","article-title":"Continuous versus bolus dosing of furosemide in the treatment of patients with acute decompensated heart failure","volume":"5","author":"Malkiwodeyar","year":"2017","journal-title":"Sch J App Med Sci."},{"issue":"12","key":"10.1016\/j.aicoj.2026.100120_bib0195","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1253\/circrep.CR-22-0107","article-title":"Effects of low-dose tolvaptan for fluid management after cardiovascular surgery","volume":"4","author":"Matsuda","year":"2022","journal-title":"Circ Rep."},{"key":"10.1016\/j.aicoj.2026.100120_bib0200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2016.06.156","article-title":"Effects of short-term administration of tolvaptan after open heart surgery","volume":"220","author":"Matsuyama","year":"2016","journal-title":"Int J Cardiol."},{"issue":"3","key":"10.1016\/j.aicoj.2026.100120_bib0205","first-page":"127","article-title":"The relationship between pharmacokinetic variables and pharmacodynamic profiles of bolus versus continuous infusion of furosemide in critically ill patients","volume":"13","author":"Mojtahedzadeh","year":"2005","journal-title":"DARU."},{"issue":"2","key":"10.1016\/j.aicoj.2026.100120_bib0210","doi-asserted-by":"crossref","first-page":"c70","DOI":"10.1159\/000108641","article-title":"Frusemide administration in critically ill patients by continuous compared to bolus therapy","volume":"107","author":"Ostermann","year":"2007","journal-title":"Nephron Clin Pract."},{"issue":"3","key":"10.1016\/j.aicoj.2026.100120_bib0215","doi-asserted-by":"crossref","DOI":"10.1186\/cc13952","article-title":"Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial","volume":"18","author":"Palazzuoli","year":"2014","journal-title":"Crit Care."},{"issue":"2","key":"10.1016\/j.aicoj.2026.100120_bib0220","first-page":"29","article-title":"Tolvaptan plus low-dose furosemide compared with titraing furosemide in acute decompensated heart failure patients who does not response to initial furosemide dose","volume":"67","author":"Pratyarattananon","year":"2022","journal-title":"Royal Thai Air Force Medical Gazette."},{"issue":"2","key":"10.1016\/j.aicoj.2026.100120_bib0225","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ehj.2017.12.005","article-title":"Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: effect on thoracic fluid content","volume":"70","author":"Ragab","year":"2018","journal-title":"Egypt Heart J."},{"issue":"6","key":"10.1016\/j.aicoj.2026.100120_bib0230","first-page":"359","article-title":"Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection","volume":"17","author":"Sager","year":"2020","journal-title":"J Geriatr Cardiol."},{"issue":"12","key":"10.1016\/j.aicoj.2026.100120_bib0235","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/00003246-199712000-00011","article-title":"Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus","volume":"25","author":"Schuller","year":"1997","journal-title":"Crit Care Med."},{"issue":"3","key":"10.1016\/j.aicoj.2026.100120_bib0240","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ihj.2014.03.006","article-title":"A prospective, randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure","volume":"66","author":"Shah","year":"2014","journal-title":"Indian Heart J."},{"issue":"2","key":"10.1016\/j.aicoj.2026.100120_bib0245","first-page":"111","article-title":"Efficacy and safety evaluation of tolvaptan on management of fluid balance after cardiovascular surgery using cardiopulmonary bypass","volume":"62","author":"Suehiro","year":"2016","journal-title":"Osaka City Med J."},{"issue":"12","key":"10.1016\/j.aicoj.2026.100120_bib0250","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/jcph.2321","article-title":"Effects of triamterene in hospitalized patients with heart failure and diuretic resistance: a randomized clinical trial","volume":"63","author":"Taban-Sadeghi","year":"2023","journal-title":"J Clin Pharmacol."},{"issue":"3","key":"10.1016\/j.aicoj.2026.100120_bib0255","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/ehf2.13286","article-title":"Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction","volume":"8","author":"Zheng","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.aicoj.2026.100120_bib0260","article-title":"Diuretic strategies in acute heart failure: a systematic review and network meta-analysis of randomized clinical trials","author":"Cannat\u00e0","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"10.1016\/j.aicoj.2026.100120_bib0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2025.08.041","article-title":"Efficacy and safety of different combinations of add-on diuretic therapy in acute heart failure: a systematic review and network meta-analysis of randomized controlled trials","volume":"258","author":"Sephien","year":"2026","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.aicoj.2026.100120_bib0270","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2025-326601","article-title":"Combinations of diuretics for acute heart failure: a systematic review with network meta-analysis and trial sequential analysis","author":"Nahiz","year":"2025","journal-title":"Heart."},{"key":"10.1016\/j.aicoj.2026.100120_bib0275","article-title":"Diuretic resistance in cardiorenal syndrome: mechanisms, monitoring and phenotype-tailored management","volume":"12","author":"Aletras","year":"2025","journal-title":"Front Cardiovasc Med."},{"issue":"1","key":"10.1016\/j.aicoj.2026.100120_bib0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ndt\/gfae146","article-title":"Acute kidney injury in acute heart failure-when to worry and when not to worry?","volume":"40","author":"Banerjee","year":"2024","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"10.1016\/j.aicoj.2026.100120_bib0285","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","article-title":"Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure","volume":"290","author":"Costello-Boerrigter","year":"2006","journal-title":"Am J Physiol Renal Physiol."},{"issue":"4","key":"10.1016\/j.aicoj.2026.100120_bib0290","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025537","article-title":"Effects of tolvaptan add-on therapy in patients with acute heart failure: meta-analysis on randomised controlled trials","volume":"9","author":"Ma","year":"2019","journal-title":"BMJ Open."},{"key":"10.1016\/j.aicoj.2026.100120_bib0295","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1367442","article-title":"The role of tolvaptan add-on therapy in patients with acute heart failure: a systematic review and network meta-analysis","volume":"11","author":"Pratama","year":"2024","journal-title":"Front Cardiovasc Med."},{"issue":"2","key":"10.1016\/j.aicoj.2026.100120_bib0300","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/aje\/kwaa205","article-title":"Meta-analysis and sparse-data bias","volume":"190","author":"Richardson","year":"2021","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.aicoj.2026.100120_bib0305","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"352","author":"Greenland","year":"2016","journal-title":"BMJ."}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S211058202600155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S211058202600155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:40:29Z","timestamp":1791970829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S211058202600155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":61,"alternative-id":["S211058202600155X"],"URL":"https:\/\/doi.org\/10.1016\/j.aicoj.2026.100120","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diuretic therapy for critically ill patients: a systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aicoj.2026.100120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise (French Intensive Care Society).","name":"copyright","label":"Copyright"}],"article-number":"100120"}}